SPARC has been shown to modulate the mitogenic activity in normal endothelial cells in a dose-dependent manner (12) and play dual roles in tumor angiogenesis and tumor extravasation and mediate permeability that is related to endothelial barrier function (13). The gene discussed is SPARC; the disease is neoplasm.